COMP <GO>
IBO vs NNVC // ALTMAN Z-SCORE & DEBT/EQUITY
Impact BioMedical Inc. (NYSE) VS. NanoViricides Inc. (NYSE) • 15-METRIC TALLY: IBO 2
— NNVC 2
■ METRIC PARITY
LAST: $4.02 (+0.25%) • MKT CAP: $34.3M
balance-sheet
5.88
LAST: $1.43 (+5.93%) • MKT CAP: $34.5M
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IBO VS. NNVC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IBO | NNVC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.50% | -35.00% | +7.50 | IBO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.72% | -23.37% | +17.65 | IBO | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 5.88 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.2 | 48.5 | -1.30 | NNVC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $34.3M | $34.5M | -$218.1K | NNVC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IBO REV | NNVC REV | IBO GROSS % | NNVC GROSS % | IBO FCF | NNVC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $32.0K | $26.9M | -50.0% | — | -$1.9M | -$8.5M |
| FY 2024 | $80.5M | $23.8M | — | — | -$2.9M | -$6.5M |
| FY 2023 | $11.3M | $25.0M | — | — | -$2.9M | -$5.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IBO // BETA —
NNVC // BETA —